According to the SEC Form 4 filings, Burkly Linda, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $20,333 | 5 | 100 |
| 2026-09-03 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 709 0.0005% | $3.04 | $2,153 | -13.64% | |
| 2026-07-28 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 4,928 0.0051% | $2.67 | $13,158 | +4.96% | |
| 2026-06-03 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 731 0.0007% | $2.70 | $1,975 | -0.54% | |
| 2026-03-03 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 749 0.0007% | $2.02 | $1,513 | +35.78% | |
| 2025-12-03 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 713 0.0008% | $2.15 | $1,535 | +11.81% | |
| 2025-09-03 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 710 0.0008% | $2.60 | $1,843 | +8.2% | |
| 2025-07-31 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 5,121 0.0061% | $2.49 | $12,757 | +5.58% | |
| 2025-06-03 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 726 0.0008% | $1.72 | $1,252 | +40.66% | |
| 2025-03-04 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 2,891 0.0034% | $1.71 | $4,946 | +25.57% | |
| 2024-07-25 | Sale | Editas Medicine, Inc. EDIT | EVP, CHIEF SCIENTIFIC OFFICER | 11,886 0.0141% | $5.42 | $64,370 | -63.11% |